Portfolio Holdings Detail for ISIN IE000G4PH2B1
Stock Name / Fund iShares S&P 500 Paris-Aligned Climate UCITS ETF USD Dist
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker UPAD(USD) LSE
ETF Ticker UPAD.L(GBP) LSE

Holdings detail for REGN

Stock Name	Regeneron Pharmaceuticals Inc
Ticker	REGN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US75886F1075
LEI	549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria: (RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages: Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL: Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors: Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN: In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC: Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.: Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.: D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares S&P 500 Paris-Aligned Climate UCITS ETF USD Dist REGN holdings

Date	Number of REGN Shares Held	Base Market Value of REGN Shares	Local Market Value of REGN Shares	Change in REGN Shares Held	Change in REGN Base Value	Current Price per REGN Share Held	Previous Price per REGN Share Held
2025-11-11 (Tuesday)	2,687	USD 1,812,516	USD 1,812,516
2025-11-10 (Monday)	2,687	USD 1,759,286	USD 1,759,286	0	USD -7,497	USD 654.74	USD 657.53
2025-11-07 (Friday)	2,687	USD 1,766,783	USD 1,766,783	0	USD 28,643	USD 657.53	USD 646.87
2025-11-06 (Thursday)	2,687	USD 1,738,140	USD 1,738,140	0	USD 7,201	USD 646.87	USD 644.19
2025-11-05 (Wednesday)	2,687	USD 1,730,939	USD 1,730,939	0	USD 43,503	USD 644.19	USD 628
2025-11-04 (Tuesday)	2,687	USD 1,687,436	USD 1,687,436	0	USD -38,290	USD 628	USD 642.25
2025-11-03 (Monday)	2,687	USD 1,725,726	USD 1,725,726	-225	USD -172,316	USD 642.25	USD 651.8
2025-10-31 (Friday)	2,912	USD 1,898,042	USD 1,898,042	9	USD -636	USD 651.8	USD 654.04
2025-10-30 (Thursday)	2,903	USD 1,898,678	USD 1,898,678	0	USD 3,280	USD 654.04	USD 652.91
2025-10-29 (Wednesday)	2,903	USD 1,895,398	USD 1,895,398	0	USD -4,557	USD 652.91	USD 654.48
2025-10-28 (Tuesday)	2,903	USD 1,899,955	USD 1,899,955	0	USD 200,800	USD 654.48	USD 585.31
2025-10-27 (Monday)	2,903	USD 1,699,155	USD 1,699,155	0	USD 21,366	USD 585.31	USD 577.95

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE000G4PH2B1

Show aggregate share trades of REGN

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-03 SELL -225 657.460 627.500 630.496 USD -141,862 635.92 Profit of 1,220 on sale
2025-10-31 BUY 9 659.760 645.000 646.476 USD 5,818 635.84
2025-10-23 SELL -36 575.690 584.000 583.169 USD -20,994 636.43 Profit of 1,917 on sale
2025-10-22 SELL -18 584.740 588.710 588.313 USD -10,590 636.70 Profit of 871 on sale
2025-10-07 SELL -162 583.240 591.450 590.629 USD -95,682 638.98 Profit of 7,832 on sale
2025-10-06 BUY 18 585.480 603.650 601.833 USD 10,833 639.27
2025-10-01 SELL -9 599.940 615.390 613.845 USD -5,525 639.92 Profit of 235 on sale
2025-09-29 SELL -153 560.750 564.910 564.494 USD -86,368 640.79 Profit of 11,674 on sale
2025-09-24 SELL -1,009 576.980 577.980 577.880 USD -583,081 642.08 Profit of 64,777 on sale
2025-09-18 BUY 12 598.710 600.000 599.871 USD 7,198 642.33
2025-09-10 SELL -24 555.830 560.000 559.583 USD -13,430 644.56 Profit of 2,039 on sale
2025-08-20 BUY 60 591.010 596.920 596.329 USD 35,780 646.48
2025-08-15 SELL -24 580.410 581.950 581.796 USD -13,963 647.79 Profit of 1,584 on sale
2025-07-21 SELL -48 545.530 552.980 552.235 USD -26,507 653.06 Profit of 4,840 on sale
2025-07-17 BUY 12 550.000 554.480 554.032 USD 6,648 654.48
2025-07-15 SELL -84 547.960 574.750 572.071 USD -48,054 655.91 Profit of 7,042 on sale
2025-07-09 SELL -24 552.580 558.380 557.800 USD -13,387 656.61 Profit of 2,371 on sale
2025-07-03 SELL -24 547.360 555.000 554.236 USD -13,302 659.70 Profit of 2,531 on sale
2025-07-02 SELL -120 547.740 551.500 551.124 USD -66,135 660.49 Profit of 13,124 on sale
2025-06-30 SELL -348 525.000 526.080 525.972 USD -183,038 661.44 Profit of 47,143 on sale
2025-06-13 SELL -72 529.240 529.550 529.519 USD -38,125 671.07 Profit of 10,192 on sale
2025-06-12 SELL -54 521.840 525.220 524.882 USD -28,344 672.20 Profit of 7,955 on sale
2025-06-11 SELL -162 518.600 528.370 527.393 USD -85,438 673.37 Profit of 23,649 on sale
2025-06-10 SELL -198 523.530 529.990 529.344 USD -104,810 674.52 Profit of 28,746 on sale
2025-06-05 BUY 54 483.070 491.770 490.900 USD 26,509 678.69
2025-05-19 SELL -9 596.540 598.560 598.358 USD -5,385 691.67 Profit of 840 on sale
2025-05-13 BUY 27 574.160 575.050 574.961 USD 15,524 695.69
2025-05-02 BUY 36 605.610 615.610 614.610 USD 22,126 704.33
2025-05-01 SELL -45 590.000 593.930 593.537 USD -26,709 705.45 Profit of 5,036 on sale
2025-04-28 SELL -153 610.860 614.830 614.433 USD -94,008 708.86 Profit of 14,448 on sale
2025-04-16 BUY 36 549.280 561.830 560.575 USD 20,181 720.49
2025-04-08 BUY 54 556.810 586.030 583.108 USD 31,488 731.78
2025-04-07 SELL -144 572.780 591.540 589.664 USD -84,912 733.67 Profit of 20,737 on sale
2025-04-04 SELL -27 573.450 612.990 609.036 USD -16,444 735.60 Profit of 3,417 on sale
2025-03-28 SELL -450 637.360 642.970 642.409 USD -289,084 741.03 Profit of 44,377 on sale
2025-03-27 SELL -18 635.830 643.430 642.670 USD -11,568 742.37 Profit of 1,795 on sale
2025-03-24 SELL -18 661.000 667.460 666.814 USD -12,003 746.26 Profit of 1,430 on sale
2025-03-21 SELL -461 658.480 661.000 660.748 USD -304,605 747.45 Profit of 39,970 on sale
2025-03-18 SELL -240 664.960 678.270 676.939 USD -162,465 750.87 Profit of 17,742 on sale
2025-03-14 SELL -70 666.870 686.980 684.969 USD -47,948 753.13 Profit of 4,771 on sale
2025-03-13 SELL -10 680.610 698.950 697.116 USD -6,971 754.20 Profit of 571 on sale
2025-03-12 BUY 100 689.500 712.460 710.164 USD 71,016 755.16
2025-03-11 BUY 130 718.160 747.700 744.746 USD 96,817 755.73
2025-03-07 BUY 60 707.510 729.750 727.526 USD 43,652 756.65
2025-03-05 BUY 130 687.150 692.790 692.226 USD 89,989 757.75
2025-02-26 BUY 20 706.940 721.410 719.963 USD 14,399 763.27
2025-02-12 BUY 20 663.860 670.980 670.268 USD 13,405 778.87
2025-02-05 BUY 40 716.720 729.250 727.997 USD 29,120 787.93
2025-01-02 BUY 425 715.190 726.810 725.648 USD 308,400 818.70
2024-12-09 SELL -9 788.000 800.990 799.691 USD -7,197 820.98 Profit of 192 on sale
2024-12-03 SELL -18 749.570 770.000 767.957 USD -13,823 829.66 Profit of 1,111 on sale
2024-12-02 BUY 9 762.340 763.890 763.735 USD 6,874 832.25
2024-11-29 BUY 18 750.220 754.510 754.081 USD 13,573 835.53
2024-11-27 BUY 45 754.870 762.160 761.431 USD 34,264 842.54
2024-11-26 BUY 54 753.030 754.180 754.065 USD 40,720 846.61
2024-11-22 BUY 18 738.000 751.400 750.060 USD 13,501 856.90
2024-11-19 BUY 18 744.600 758.600 757.200 USD 13,630 876.79
2024-11-18 BUY 27 762.000 762.700 762.630 USD 20,591 883.97
2024-11-12 BUY 9 821.000 831.000 830.000 USD 7,470 888.17
2024-11-05 BUY 90 829.430 836.630 835.910 USD 75,232 911.23
2024-10-31 BUY 36 838.200 883.150 878.655 USD 31,632 939.11
2024-10-30 BUY 135 922.790 935.860 934.553 USD 126,165 941.44
2024-10-21 BUY 18 968.500 991.240 988.966 USD 17,801 0.00
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-03	SELL	-225	657.460	627.500	630.496	USD -141,862	635.92 Profit of 1,220 on sale
2025-10-31	BUY	9	659.760	645.000	646.476	USD 5,818	635.84
2025-10-23	SELL	-36	575.690	584.000	583.169	USD -20,994	636.43 Profit of 1,917 on sale
2025-10-22	SELL	-18	584.740	588.710	588.313	USD -10,590	636.70 Profit of 871 on sale
2025-10-07	SELL	-162	583.240	591.450	590.629	USD -95,682	638.98 Profit of 7,832 on sale
2025-10-06	BUY	18	585.480	603.650	601.833	USD 10,833	639.27
2025-10-01	SELL	-9	599.940	615.390	613.845	USD -5,525	639.92 Profit of 235 on sale
2025-09-29	SELL	-153	560.750	564.910	564.494	USD -86,368	640.79 Profit of 11,674 on sale
2025-09-24	SELL	-1,009	576.980	577.980	577.880	USD -583,081	642.08 Profit of 64,777 on sale
2025-09-18	BUY	12	598.710	600.000	599.871	USD 7,198	642.33
2025-09-10	SELL	-24	555.830	560.000	559.583	USD -13,430	644.56 Profit of 2,039 on sale
2025-08-20	BUY	60	591.010	596.920	596.329	USD 35,780	646.48
2025-08-15	SELL	-24	580.410	581.950	581.796	USD -13,963	647.79 Profit of 1,584 on sale
2025-07-21	SELL	-48	545.530	552.980	552.235	USD -26,507	653.06 Profit of 4,840 on sale
2025-07-17	BUY	12	550.000	554.480	554.032	USD 6,648	654.48
2025-07-15	SELL	-84	547.960	574.750	572.071	USD -48,054	655.91 Profit of 7,042 on sale
2025-07-09	SELL	-24	552.580	558.380	557.800	USD -13,387	656.61 Profit of 2,371 on sale
2025-07-03	SELL	-24	547.360	555.000	554.236	USD -13,302	659.70 Profit of 2,531 on sale
2025-07-02	SELL	-120	547.740	551.500	551.124	USD -66,135	660.49 Profit of 13,124 on sale
2025-06-30	SELL	-348	525.000	526.080	525.972	USD -183,038	661.44 Profit of 47,143 on sale
2025-06-13	SELL	-72	529.240	529.550	529.519	USD -38,125	671.07 Profit of 10,192 on sale
2025-06-12	SELL	-54	521.840	525.220	524.882	USD -28,344	672.20 Profit of 7,955 on sale
2025-06-11	SELL	-162	518.600	528.370	527.393	USD -85,438	673.37 Profit of 23,649 on sale
2025-06-10	SELL	-198	523.530	529.990	529.344	USD -104,810	674.52 Profit of 28,746 on sale
2025-06-05	BUY	54	483.070	491.770	490.900	USD 26,509	678.69
2025-05-19	SELL	-9	596.540	598.560	598.358	USD -5,385	691.67 Profit of 840 on sale
2025-05-13	BUY	27	574.160	575.050	574.961	USD 15,524	695.69
2025-05-02	BUY	36	605.610	615.610	614.610	USD 22,126	704.33
2025-05-01	SELL	-45	590.000	593.930	593.537	USD -26,709	705.45 Profit of 5,036 on sale
2025-04-28	SELL	-153	610.860	614.830	614.433	USD -94,008	708.86 Profit of 14,448 on sale
2025-04-16	BUY	36	549.280	561.830	560.575	USD 20,181	720.49
2025-04-08	BUY	54	556.810	586.030	583.108	USD 31,488	731.78
2025-04-07	SELL	-144	572.780	591.540	589.664	USD -84,912	733.67 Profit of 20,737 on sale
2025-04-04	SELL	-27	573.450	612.990	609.036	USD -16,444	735.60 Profit of 3,417 on sale
2025-03-28	SELL	-450	637.360	642.970	642.409	USD -289,084	741.03 Profit of 44,377 on sale
2025-03-27	SELL	-18	635.830	643.430	642.670	USD -11,568	742.37 Profit of 1,795 on sale
2025-03-24	SELL	-18	661.000	667.460	666.814	USD -12,003	746.26 Profit of 1,430 on sale
2025-03-21	SELL	-461	658.480	661.000	660.748	USD -304,605	747.45 Profit of 39,970 on sale
2025-03-18	SELL	-240	664.960	678.270	676.939	USD -162,465	750.87 Profit of 17,742 on sale
2025-03-14	SELL	-70	666.870	686.980	684.969	USD -47,948	753.13 Profit of 4,771 on sale
2025-03-13	SELL	-10	680.610	698.950	697.116	USD -6,971	754.20 Profit of 571 on sale
2025-03-12	BUY	100	689.500	712.460	710.164	USD 71,016	755.16
2025-03-11	BUY	130	718.160	747.700	744.746	USD 96,817	755.73
2025-03-07	BUY	60	707.510	729.750	727.526	USD 43,652	756.65
2025-03-05	BUY	130	687.150	692.790	692.226	USD 89,989	757.75
2025-02-26	BUY	20	706.940	721.410	719.963	USD 14,399	763.27
2025-02-12	BUY	20	663.860	670.980	670.268	USD 13,405	778.87
2025-02-05	BUY	40	716.720	729.250	727.997	USD 29,120	787.93
2025-01-02	BUY	425	715.190	726.810	725.648	USD 308,400	818.70
2024-12-09	SELL	-9	788.000	800.990	799.691	USD -7,197	820.98 Profit of 192 on sale
2024-12-03	SELL	-18	749.570	770.000	767.957	USD -13,823	829.66 Profit of 1,111 on sale
2024-12-02	BUY	9	762.340	763.890	763.735	USD 6,874	832.25
2024-11-29	BUY	18	750.220	754.510	754.081	USD 13,573	835.53
2024-11-27	BUY	45	754.870	762.160	761.431	USD 34,264	842.54
2024-11-26	BUY	54	753.030	754.180	754.065	USD 40,720	846.61
2024-11-22	BUY	18	738.000	751.400	750.060	USD 13,501	856.90
2024-11-19	BUY	18	744.600	758.600	757.200	USD 13,630	876.79
2024-11-18	BUY	27	762.000	762.700	762.630	USD 20,591	883.97
2024-11-12	BUY	9	821.000	831.000	830.000	USD 7,470	888.17
2024-11-05	BUY	90	829.430	836.630	835.910	USD 75,232	911.23
2024-10-31	BUY	36	838.200	883.150	878.655	USD 31,632	939.11
2024-10-30	BUY	135	922.790	935.860	934.553	USD 126,165	941.44
2024-10-21	BUY	18	968.500	991.240	988.966	USD 17,801	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	208,659	1,635	312,812	66.7%
2025-09-18	236,485	3,679	387,519	61.0%
2025-09-17	229,191	716	370,895	61.8%
2025-09-16	173,632	584	271,020	64.1%
2025-09-15	204,491	251	334,496	61.1%
2025-09-12	117,504	33	222,760	52.7%
2025-09-11	125,478	3,137	286,516	43.8%
2025-09-10	195,068	481	339,885	57.4%
2025-09-09	129,168	994	274,520	47.1%
2025-09-08	250,895	396	527,062	47.6%
2025-09-05	170,149	290	289,566	58.8%
2025-09-04	188,227	2,103	360,619	52.2%
2025-09-03	185,679	344	438,111	42.4%
2025-09-02	191,954	138	476,288	40.3%
2025-08-29	133,226	685	236,726	56.3%
2025-08-28	116,560	2,177	256,675	45.4%
2025-08-27	113,719	465	243,836	46.6%
2025-08-26	210,376	450	400,199	52.6%
2025-08-25	149,130	68	363,377	41.0%
2025-08-22	211,822	3,244	701,770	30.2%
2025-08-21	257,492	3,416	446,439	57.7%
2025-08-20	327,738	572	559,133	58.6%
2025-08-19	118,472	2,191	324,311	36.5%
2025-08-18	146,282	388	277,909	52.6%
2025-08-15	209,923	3,375	441,752	47.5%
2025-08-14	157,569	3,623	429,327	36.7%
2025-08-13	111,342	233	362,786	30.7%
2025-08-12	117,647	171	310,775	37.9%
2025-08-11	129,513	2,676	284,757	45.5%
2025-08-08	128,559	1,038	431,841	29.8%
2025-08-07	166,648	1,560	352,877	47.2%
2025-08-06	176,311	624	397,089	44.4%
2025-08-05	154,257	115	353,744	43.6%
2025-08-04	200,758	1,913	409,897	49.0%
2025-08-01	349,775	3,745	728,720	48.0%
2025-07-31	222,350	476	549,344	40.5%
2025-07-30	106,839	1,689	231,761	46.1%
2025-07-29	149,359	276	292,667	51.0%
2025-07-28	103,687	1,380	245,287	42.3%
2025-07-25	103,783	556	259,069	40.1%
2025-07-24	156,974	2,397	291,677	53.8%
2025-07-23	168,734	1,708	355,372	47.5%
2025-07-22	116,324	617	304,880	38.2%
2025-07-21	98,482	900	250,107	39.4%
2025-07-18	183,174	1,051	391,909	46.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares S&P 500 Paris-Aligned Climate UCITS ETF USD Dist
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	UPAD(USD) LSE
ETF Ticker	UPAD.L(GBP) LSE